{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:46:38Z","timestamp":1791899198821,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,13]]},"DOI":"10.7759\/cureus.117849","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:55:16Z","timestamp":1791896116000},"source":"Crossref","is-referenced-by-count":0,"title":["\u201cGas Station Heroin\u201d in Plain Sight: Tianeptine Misuse, Detection Gaps, and the Role of Substance-Use Screening"],"prefix":"10.7759","author":[{"given":"Nelson  J","family":"Tiburcio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scarlett L","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-023-00539-5","article-title":"Tianeptine, an antidepressant with opioid agonist effects: pharmacology and abuse potential, a narrative review","volume":"12","author":"Edinoff AN","year":"2023","unstructured":"Edinoff AN, Sall S, Beckman SP, et al.. Tianeptine, an antidepressant with opioid agonist effects: pharmacology and abuse potential, a narrative review. Pain Ther. 2023, 12:1121-34. 10.1007\/s40122-023-00539-5","journal-title":"Pain Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2018.1438687","article-title":"Tianeptine abuse and dependence in psychiatric patients: a review of 18 case reports in the literature","volume":"50","author":"Springer J","year":"2018","unstructured":"Springer J, Cuba\u0142a WJ. Tianeptine abuse and dependence in psychiatric patients: a review of 18 case reports in the literature. J Psychoactive Drugs. 2018, 50:275-80. 10.1080\/02791072.2018.1438687","journal-title":"J Psychoactive Drugs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2023.01.003","article-title":"A case of AKI in a patient with tianeptine toxicity","volume":"81","author":"Abouelsaad M","year":"2023","unstructured":"Abouelsaad M, Butler S, Kassem H. A case of AKI in a patient with tianeptine toxicity. Am J Kidney Dis. 2023, 81:S1. 10.1053\/j.ajkd.2023.01.003","journal-title":"Am J Kidney Dis"},{"key":"ref4","unstructured":"Federal Register. Schedules of controlled substances. placement of tianeptine in Schedule I. Drug Enforcement Administration. (2026). Accessed: September 26, 2026: https:\/\/www.federalregister.gov\/documents\/2026\/07\/08\/2026-13821\/schedules-of-controlled-substances-placement-of-tiane...."},{"key":"ref5","unstructured":"Nootropic. Wikipedia. (2026). Accessed. September 29, 2026: https:\/\/en.wikipedia.org\/wiki?curid=685457."},{"key":"ref6","unstructured":"Nootropic. Oxford English Dictionary. (2003). Accessed. August 21, 2026: https:\/\/www.oed.com\/dictionary\/nootropic_adj."},{"key":"ref7","unstructured":"Operation Supplement Safety. Nootropics. drugs vs dietary supplements for brain health. (2023). Accessed: August 21, 2026: https:\/\/www.opss.org\/article\/nootropics-drugs-vs-dietary-supplements-brain-health."},{"key":"ref8","unstructured":"FTC and FDA send warning letters to companies selling dietary supplements claiming to treat Alzheimer's disease and remediate or cure other serious illnesses such as Parkinson's, heart disease, and cancer. (2019). Accessed. August 22, 2026: https:\/\/www.ftc.gov\/news-events\/news\/press-releases\/2019\/02\/ftc-fda-send-warning-letters-companies-selling-dietary-su...."},{"key":"ref9","unstructured":"U.S. Food & Drug Administration. Health fraud scams. Unproven Alzheimer's disease products. (2018). Accessed. August 22, 2026: https:\/\/www.fda.gov\/consumers\/health-fraud-scams\/unproven-alzheimers-disease-products."},{"key":"ref10","article-title":"Pharmacology of integrative activity of the brain. Attempt at nootropic concept in psychopharmacology [Article in French]","volume":"25","author":"Giurgea C","year":"1972","unstructured":"Giurgea C. Pharmacology of integrative activity of the brain. Attempt at nootropic concept in psychopharmacology [Article in French]. Actual Pharmacol (Paris). 1972, 25:115-56.","journal-title":"Actual Pharmacol (Paris)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0364-7722(77)90046-7","article-title":"Nootropic drugs","volume":"1","author":"Giurgea C","year":"1977","unstructured":"Giurgea C, Salama M. Nootropic drugs. Prog Neuro-Psychopharmacol. 1977, 1:235-47. 10.1016\/0364-7722(77)90046-7","journal-title":"Prog Neuro-Psychopharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/nu14163367","article-title":"Nootropics as cognitive enhancers: types, dosage and side effects of smart drugs","volume":"14","author":"Mal\u00edk M","year":"2022","unstructured":"Mal\u00edk M, Tlusto\u0161 P. Nootropics as cognitive enhancers: types, dosage and side effects of smart drugs. Nutrients. 2022, 14:3367. 10.3390\/nu14163367","journal-title":"Nutrients"},{"key":"ref13","unstructured":"New \u201cgas station heroin\u201d tianeptine product trend. U.S. Food & Drug Administration. (2025). Accessed. August 24, 2026: https:\/\/www.fda.gov\/consumers\/health-fraud-scams\/new-gas-station-heroin-tianeptine-product-trend."},{"key":"ref14","unstructured":"What you need to know about \u2018gas station heroin.\u2019 VCUHealth. (2025). Accessed. August 25, 2026: https:\/\/www.vcuhealth.org\/news\/what-you-need-to-know-about-gas-station-heroin\/."},{"key":"ref15","unstructured":"PubChem compound summary for CID 68870, tianeptine. (2026). Accessed. October 5, 2026: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tianeptine."},{"key":"ref16","unstructured":"8 things to know about the drug known as 'gas station heroin.' NPR. (2024). Accessed. September 1, 2026: https:\/\/www.npr.org\/2024\/07\/12\/nx-s1-4865955\/tianeptine-gas-station-heroin-drug."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/01.NAJ.0001016316.12810.5d","article-title":"FDA issues warning about \u2018gas station heroin\u2019","volume":"124","author":"Roush K","year":"2024","unstructured":"Roush K. FDA issues warning about \u2018gas station heroin\u2019. Am J Nurs. 2024, 124:13. 10.1097\/01.NAJ.0001016316.12810.5d","journal-title":"Am J Nurs"},{"key":"ref18","unstructured":"Know the dangers of 'gas station heroin.' Health essentials. Cleveland Clinic. (2024). Accessed. September 2, 2026: https:\/\/health.clevelandclinic.org\/gas-station-heroin-tianeptine."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40688","article-title":"From antidepressant tianeptine to street drug ZaZa: a narrative review","volume":"15","author":"Wagner ML","year":"2023","unstructured":"Wagner ML, Pergolizzi J Jr, LeQuang JA, Breve F, Varrassi G. From antidepressant tianeptine to street drug ZaZa: a narrative review. Cureus. 2023, 15:e40688. 10.7759\/cureus.40688","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6730a2","article-title":"Characteristics of tianeptine exposures reported to the National Poison Data System \u2014 United States, 2000-2017","volume":"67","author":"El Zahran T","year":"2018","unstructured":"El Zahran T, Schier J, Glidden E, et al.. Characteristics of tianeptine exposures reported to the National Poison Data System \u2014 United States, 2000-2017. MMWR Morb Mortal Wkly Rep. 2018, 67:815-8. 10.15585\/mmwr.mm6730a2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2007.03.035","article-title":"Fatal intoxication with tianeptine (Stablon)","volume":"170","author":"Proen\u00e7a P","year":"2007","unstructured":"Proen\u00e7a P, Teixeira H, Pinheiro J, Monsanto PV, Vieira DN. Fatal intoxication with tianeptine (Stablon). Forensic Sci Int. 2007, 170:200-3. 10.1016\/j.forsciint.2007.03.035","journal-title":"Forensic Sci Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bky023","article-title":"Case reports of fatalities involving tianeptine in the United States","volume":"42","author":"Bakota EL","year":"2018","unstructured":"Bakota EL, Samms WC, Gray TR, Oleske DA, Hines MO. Case reports of fatalities involving tianeptine in the United States. J Anal Toxicol. 2018, 42:503-9. 10.1093\/jat\/bky023","journal-title":"J Anal Toxicol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5455\/bcp.20130426010958","article-title":"Risk management in tianeptine abuse in Turkey: a national experience","volume":"23","author":"Durmus N","year":"2013","unstructured":"Durmus N, Ozbilen G, Kasap Y, et al.. Risk management in tianeptine abuse in Turkey: a national experience. Bulletin of Clinical Psychopharmacology. 2013, 23:149-54. 10.5455\/bcp.20130426010958","journal-title":"Bulletin of Clinical Psychopharmacology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.95153","article-title":"Gas station heroin: a case report of tianeptine use disorder and a literature review","volume":"17","author":"Kandra K","year":"2025","unstructured":"Kandra K, Gajagowni R, Fernandez GA, Polechonski N, Blewett BP. Gas station heroin: a case report of tianeptine use disorder and a literature review. Cureus. 2025, 17:e95153. 10.7759\/cureus.95153","journal-title":"Cureus"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1016\/S0090-9556(25)08654-4","article-title":"The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers","volume":"18","author":"Grislain L","year":"1990","unstructured":"Grislain L, Gele P, Bertrand M, Luijten W, Bromet N, Salvadori C, Kamoun A. The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers. Drug Metab Dispos. 1990, 18:804-8.","journal-title":"Drug Metab Dispos"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkx034","article-title":"Acute toxicity from intravenous use of the tricyclic antidepressant tianeptine","volume":"41","author":"Dempsey SK","year":"2017","unstructured":"Dempsey SK, Poklis JL, Sweat K, Cumpston K, Wolf CE. Acute toxicity from intravenous use of the tricyclic antidepressant tianeptine. J Anal Toxicol. 2017, 41:547-50. 10.1093\/jat\/bkx034","journal-title":"J Anal Toxicol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkab005","article-title":"Lack of cross-reactivity of tianeptine with tricyclic antidepressant immunoassays","volume":"45","author":"Badea A","year":"2021","unstructured":"Badea A, Ghosh R, Lynch KL, Wu AH. Lack of cross-reactivity of tianeptine with tricyclic antidepressant immunoassays. J Anal Toxicol. 2021, 45:e8-9. 10.1093\/jat\/bkab005","journal-title":"J Anal Toxicol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1027\/1015-5759\/a000359","article-title":"Validation of the adult Substance Abuse Subtle Screening Inventory-4 (SASSI-4)","volume":"35","author":"Lazowski LE","year":"2016","unstructured":"Lazowski LE, Geary BB. Validation of the adult Substance Abuse Subtle Screening Inventory-4 (SASSI-4). Eur J Psychol Assess. 2016, 35:86-97. 10.1027\/1015-5759\/a000359","journal-title":"Eur J Psychol Assess"},{"key":"ref29","article-title":"The Adult Substance Abuse Subtle Screening Inventory-4 (SASSI-4) user guide & manual","author":"Lazowski LE","year":"2016","unstructured":"Lazowski LE, Kimmell KS, Baker SL. The Adult Substance Abuse Subtle Screening Inventory-4 (SASSI-4) user guide & manual. The SASSI Institute, Springville, IN; 2016."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/540329-gas-station-heroin-in-plain-sight-tianeptine-misuse-detection-gaps-and-the-role-of-substance-use-screening","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:55:19Z","timestamp":1791896119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/540329-gas-station-heroin-in-plain-sight-tianeptine-misuse-detection-gaps-and-the-role-of-substance-use-screening"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.117849","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,13]]}}}